dc.contributor.author | Mccue, S. | |
dc.contributor.author | Yazici, Y. | |
dc.contributor.author | Cheng, S. | |
dc.contributor.author | Paris, M. | |
dc.contributor.author | Chen, M. | |
dc.contributor.author | Hatemi, G. | |
dc.contributor.author | Mahr, A. | |
dc.contributor.author | Takeno, M. | |
dc.contributor.author | Kim, D. Y. | |
dc.contributor.author | Melikoglu, M. | |
dc.date.accessioned | 2021-03-04T12:27:32Z | |
dc.date.available | 2021-03-04T12:27:32Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Hatemi G., Mahr A., Takeno M., Kim D. Y. , Melikoglu M., Cheng S., Mccue S., Paris M., Chen M., Yazici Y., "Apremilast for the treatment of oral ulcers in Behcet's syndrome: a phase III randomized, double-blind, placebo-controlled study (RELIEF)", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.36, sa.6, 2018 | |
dc.identifier.issn | 0392-856X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_776480ce-6245-455c-9412-e22a14247f19 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/81969 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Apremilast for the treatment of oral ulcers in Behcet's syndrome: a phase III randomized, double-blind, placebo-controlled study (RELIEF) | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 36 | |
dc.identifier.issue | 6 | |
dc.contributor.firstauthorID | 250626 | |